Discontinuation risk from adverse events: immunotherapy alone vs. combined with chemotherapy: a systematic review and network meta-analysis by Sangwon Shin, Jimin Moon, Chiyoon Oum, Seulki Kim, Soo Ick Cho, Yoojoo Lim, Chan-Young Ock, Seunghwan Shin

Get full text

1446 Pan-cancer methylation analysis reveals a significant correlation of immune-desert phenotype with methylation aberrancy by Sergio Pereira, Chan-Young Ock, Seulki Kim, Siraj Ali, Jinhee Lee, Sanghoon Song, Seonwook Park, Chang Ho Ahn

921 Comparison of PI3K/AKT/mTOR pathway profiles amongst three immune phenotypes classified by artificial intelligence-powered H&E analyzer in non-small cell lung cancer by Chan-Young Ock, Young Kwang Chae, Grace Lee, Kyunghyun Paeng, Sanghoon Song, Hyung-Gyo Cho, Hye Sung Kim

1293 Fragmented pattern of tumor mass is related to fibroblast activation mitigating spatial interaction between tumor and immune cells by Chan-Young Ock, Seulki Kim, Siraj Ali, Sanghoon Song, Donggeun Yoo, Sukjun Kim, Mingu Kang, Mohammad Mostafavi, Chang Ho Ahn

Deep Learning Analysis of CT Images Reveals High-Grade Pathological Features to Predict Survival in Lung Adenocarcinoma by Yeonu Choi, Jaehong Aum, Se-Hoon Lee, Hong-Kwan Kim, Jhingook Kim, Seunghwan Shin, Ji Yun Jeong, Chan-Young Ock, Ho Yun Lee

Get full text

Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer by Chan-Young Ock, Shin-Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Yoon Kyung Jeon, Dong-Wan Kim, Doo Hyun Chung, Dae Seog Heo

Get full text

Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer by Chang Hyun Nam, Jaemoon Koh, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Dong-Wan Kim, Doo Hyun Chung, Dae Seog Heo

Get full text

Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients by Soo Youn Cho, Jeong Hoon Lee, Jai Min Ryu, Jeong Eon Lee, Eun Yoon Cho, Chang Ho Ahn, Kyunghyun Paeng, Inwan Yoo, Chan-Young Ock, Sang Yong Song

Get full text

Author Correction: Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients by Soo Youn Cho, Jeong Hoon Lee, Jai Min Ryu, Jeong Eon Lee, Eun Yoon Cho, Chang Ho Ahn, Kyunghyun Paeng, Inwan Yoo, Chan-Young Ock, Sang Yong Song

Get full text

288 A phase 1 study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors by Bhumsuk Keam, Chan-Young Ock, Tae Min Kim, Do-Youn Oh, Jeeyun Lee, Won Ki Kang, Yeon Hee Park, Ji Hye Lee, Yun Jeong Song, Young Suk Park

High tumoral PD-L1 expression and low PD-1+ or CD8+ tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervou... by Sehui Kim, Soo Jeong Nam, Changhee Park, Dohee Kwon, Jeemin Yim, Seung Geun Song, Chan-Young Ock, Young A Kim, Sung Hye Park, Tae Min Kim, Yoon Kyung Jeon

Get full text

The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase‐positive non‐small cell lung cancer by Ja Yoon Heo, Changhee Park, Bhumsuk Keam, Chan‐Young Ock, Miso Kim, Tae Min Kim, Dong‐Wan Kim, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Dae Seog Heo

Get full text

332 Novel TGF-β signatures in metastatic colorectal cancer patients treated with vactosertib in combination with pembrolizumab by Chan-Young Ock, Keun-Wook Lee, Young Suk Park, Joong Bae Ahn, Jin Kyung Lee, Jiyeon Ryu, Bitna Oh, Sunjin Hwang, Ki Baik Hahm, Seong-Jin Kim, Tae Won Kim

1308 Artificial intelligence (AI)-powered immune phenotyping based on programmed death ligand 1 (PD-L1) immunohistochemistry (IHC) in triple negative breast cancer (TNBC) by Chan-Young Ock, Seulki Kim, Siraj Ali, Soo Ick Cho, Gahee Park, Seunghwan Shin, Jeongun Ryu, Seonwook Park, Sangwon Shin, Taebum Lee, Juneyoung Ro, Aaron Valero, Biagio Brattoli, Changho Ahn

Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma by Hyerim Ha, Bhumsuk Keam, Chan-Young Ock, Tae Min Kim, Jin Ho Kim, Eun-Jae Chung, Seong Keun Kwon, Soon-Hyun Ahn, Hong-Gyun Wu, Myung-Whun Sung, Dae Seog Heo

Get full text

202 Spatial analysis of tumor-infiltrating lymphocytes in tumor microenvironment in non-small cell lung cancer patients who have resistance after EGFR tyrosine kinase inhibitors by Chan-Young Ock, Myung Ju Ahn, Sehhoon Park, Se-Hoon Lee, Jin Seok Ahn, Yoon-La Choi, Hyun Ae Jung, Seunghwan Shin, Chang Ho Ahn, Yeong Hak Bang, CheolYong Joe

Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer by Sangjoon Choi, Soo Ick Cho, Wonkyung Jung, Taebum Lee, Su Jin Choi, Sanghoon Song, Gahee Park, Seonwook Park, Minuk Ma, Sérgio Pereira, Donggeun Yoo, Seunghwan Shin, Chan-Young Ock, Seokhwi Kim

Get full text

961 Tumor-infiltrating lymphocytes in tumor microenvironment assessed by artificial intelligence powered H&E image analyzer is correlated with immunomodulatory subtype of triple-ne... by Chan-Young Ock, Seulki Kim, Siraj Ali, Soo Ick Cho, Seunghwan Shin, Yoojoo Lim, Heon Song, Donggeun Yoo, Taebum Lee, Mingu Kang, Chang Ho Ahn, Jimin Moon, Ken Nesmith, Seokhwi Kim

Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint... by Changhee Park, Dong Young Jeong, Yeonu Choi, You Jin Oh, Jonghoon Kim, Jeongun Ryu, Kyunghyun Paeng, Se-Hoon Lee, Se-Hoon Lee, Chan-Young Ock, Ho Yun Lee, Ho Yun Lee

Get full text

74 Tumor microenvironment based on PD-L1 and CD8 T-cell infiltration correlated with the response of MSS mCRC patients treated vactosertib in combination with pembrolizumab by Chan-Young Ock, Keun-Wook Lee, Young Suk Park, Joong Bae Ahn, Jiyeon Ryu, Bitna Oh, Sunjin Hwang, Ki Baik Hahm, Seong-Jin Kim, Tae Won Kim, Hyejoo Park, Bo-Kyoung Kim